Japanese mid-size drugmaker Otsuka Pharmaceutical announced that it has entered into an exclusive worldwide licensing ...

Germany’s Evotec says it has taken notice of the statement made by Halozyme Therapeutics on November 22, stating that it has withdrawn its non-binding proposal to acquire Evotec for 11.00 euros per ...

Japanese drugmaker Chugai, which is majority owned by Roche, On Friday revealed that Zenyaku Kogyo has obtained regulatory ...

Japanese drugmaker Takeda (TYO: 4502) has launched Fruzaqla (fruquintinib) in its home country. This follows the approval of ...

Chinese biopharma CStone Pharmaceuticals has announced a strategic commercial collaboration with Pharmalink Store, a prominent pharmaceutical company based in the United Arab Emirates (UAE).

Akeso is awaiting approval from China's medicines regulator for a penpulimab-anlotinib combination therapy for advanced liver ...

US biotech Paragon Therapeutics yesterday revealed that biotech industry veteran Susanna High has been appointed as chief ...

The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human ...

Zai Lab and Pfizer have partnered for the commercialization of Xacduro (sulbactam-durlobactam) in China, targeting carbapenem ...

California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up ...

AstraZeneca faces challenges in securing full FDA approval for Andexxa, its anticoagulant reversal therapy, due to safety ...

Sino Biopharm has invested $20 million to acquire a 4.91% stake in LaNova Medicines, securing rights to LM-108 and other ...